Cure LGS 365 Research Grants
Cure LGS 365 Research Grants support researchers conducting basic, translational, and clinical studies to close gaps in Lennox-Gastaut Syndrome knowledge, develop therapies, and improve patient care.
Browse similar grants
Funder: Lennox-Gastaut Syndrome Foundation
Due Dates: Rolling (LOIs year-round) | Within 90 days of invitation (Full proposals)
Funding Amounts: Grants of up to $25,000, $50,000, or $75,000 for 1–2 years
Summary: Supports innovative basic, translational, and clinical research advancing understanding and care of Lennox-Gastaut Syndrome (LGS).
Key Information: Projects must be directly relevant to LGS and demonstrate a clear pathway to patient-community impact.
Description
The Lennox-Gastaut Syndrome Foundation’s Cure LGS 365 Research Grants program seeds innovative basic, translational, and clinical research addressing critical gaps in LGS knowledge, therapeutic development, or clinical care. The year-round program accepts unsolicited proposals and seeks projects with a clear pathway toward impact for the LGS patient community.
Research priorities span the syndrome’s natural history, mortality, neurodegeneration, and biomarkers predicting disease course or treatment response. The program also supports medical device research and disease-modifying therapies targeting the LGS Secondary Brain Network. Its scope extends beyond seizures to sleep, non-seizure issues, quality of life, and pediatric-to-adult care transitions, alongside approaches to preventing, reversing, or stabilizing LGS.
